CMTA

CMTA

Signal active

Investment Firm

Overview

The CMTA is aggressively pursuing treatments and a cure for all types of CMT. Since launching the Strategy to Accelerate Research (STAR) in 2008, the CMTA has been working with preeminent researchers, clinicians, patients and institutions in the global inherited neuropathy community to capitalize on breakthroughs in genetics. The CMTA has made unprecedented progress toward therapies for virtually almost all types of CMT. Since the inception of STAR, the CMTA has financed more than 100 projects and committed over $23.5 million in research. Thanks to support from our donors, STAR continues to gain momentum and the promise of breakthroughs is imminent.

Highlights

Founded

1983

Industry

Non Profit

Employees

11-50

Investment

1

Lead Investment

1

Exits

undefined

Stages

Seed

Investor Type

N/A

Location

United States, North America

Contact Information

Social

Profile Resume

CMTA, established in 1983 and headquartered in United States, North America., specializes in Seed investments across Biotechnology, Biopharma, Health Diagnostics. Their recent investments include Armatus Bio. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Suzanne L. Bruhn

Suzanne L. Bruhn

CEO

Investment portfolio

N/A

investments

1

Diversity investments

0

Lead investments

1

Number of exits

undefined

Investments

1

Annouced DateOrganization NameIndustryMoney Raised
Nov 16, 2023
Armatus Bio Armatus Bio
Biotechnologynull

Exits

0

Funding Timeline

Funding rounds

1

Investors

0

Funds

0

Funding Rounds

1

CMTA has raised 1 rounds. Their latest funding was raised on Nov 16, 2023 from a Seed Round - Armatus Bio round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Nov 16, 2023
Seed Round - Armatus Bio Seed Round - Armatus Bio
-0-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.